R&D Q4 Clinical trials round-up: October to December 2025 We round up the key data and innovations in Q4 2025 - and what these likely presage for 2026’s R&D focus.
Sales & Marketing Sponsored The AI imperative: Establishing the standard for modern clin... The findings from the Medidata-commissioned survey confirm that AI implementation in clinical trials has moved firmly beyond theoretical discussion.
Digital Sponsored Data managers and CRAs warn of rising data quality risks due... A new industry report uncovers the scope of a long-ignored problem in clinical trial operations.
News Thermo bids $8.9bn for clinical trial data firm Clario Thermo Fisher Scientific has signed a deal to acquire Clario for nearly $8.9bn in cash in a major expansion of its clinical research capabilities.
R&D Transforming drug development with statistical methodologies The product development lifecycle is long and challenging.
Digital Enhancing rare disease trials: eCOA technology’s impact on s... Sickle cell disease (SCD) affects an estimated 20 million people worldwide.
Patients LSX2026: On promise and patience, with Hans Schambye At LSX World Congress 2026 in Lisbon, Portugal, web editor Nicole Raleigh spoke with Hans Schambye, CEO of BOOST Pharma.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
